Preoperative Hypoglycemia in a Patient Receiving Insulin Detemir

被引：1

作者：

Olson, Ronald P. ^{[1
]}

Bethel, M. Angelyn ^{[2
,3
]}

Lien, Lillian ^{[2
,3
]}

机构：

[1] Duke Univ, Dept Anesthesiol, Preoperat Screening Unit, Durham, NC 27710 USA

[2] Duke Univ, Div Endocrinol, Durham, NC 27710 USA

[3] Duke Univ, Dept Med, Durham, NC 27710 USA

来源：

ANESTHESIA AND ANALGESIA | 2009年 / 108卷 / 06期

关键词：

MYOCARDIAL-INFARCTION; DIABETES-MELLITUS; MORTALITY; GLARGINE; THERAPY; VARIABILITY; MANAGEMENT; INFUSION;

D O I：

10.1213/ane.0b013e3181a2a777

中图分类号：

R614 [麻醉学];

学科分类号：

100217 ;

摘要：

The insulin regimen of a Type 2 diabetic presenting for surgery had been changed recently from a 70/30 mixture of insulin aspart protamine and aspart to insulin detemir and insulin glulisine. Preoperative instructions were to take the usual dose of basal, but none of the short-acting insulin. On the morning of surgery, the patient's blood glucose was low and remained so despite IV dextrose administration. A review of the basal insulin dose revealed that it had been inappropriately increased to control elevated postprandial glucose. Doses of basal insulin in excess of basal requirements will cause hypoglycemia in the fasting state. (Anesth Analg 2009;108:1836-8)

引用

页码：1836 / 1838

页数：3

共 50 条

[31] Association Between the Use of Long-Acting Insulin and Hypoglycemia in Nondiabetic Patients in the Surgical Intensive Care Unit [J].

Masse, Jordan ;

Giuliano, Christopher Alan ;

Brown, Sara ;

Paxton, Renee Alexander .

JOURNAL OF INTENSIVE CARE MEDICINE, 2018, 33 (05) :317-321

[32] Frequent Reoccurrence of Hypoglycemia in a Type 2 Diabetic Patient with Insulin Antibodies [J].

Zhao, Tie-Yun ;

Li, Fang ;

Xiong, Zhong-Yun .

MOLECULAR DIAGNOSIS & THERAPY, 2010, 14 (04) :237-241

[33] Hypoglycemia in patient with type 2 diabetes treated with insulin: it can happen [J].

Heller, Simon R. ;

Peyrot, Mark ;

Oates, Shannon K. ;

Taylor, April D. .

BMJ OPEN DIABETES RESEARCH & CARE, 2020, 8 (01)

[34] Successful Control of Hypoglycemia with Pasireotide LAR in a Patient with Inappropriate Insulin Secretion [J].

Rouland, Alexia ;

Bouillet, Benjamin ;

Legris, Pauline ;

Simoneau, Isabelle ;

Petit, Jean-Michel ;

Verges, Bruno .

CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2021, 13 :33-37

[35] IMPACT OF STRUCTURED INSULIN ORDER SETS ON INPATIENT HYPOGLYCEMIA AND GLYCEMIC CONTROL [J].

Kravchenko, Maria, I ;

Tate, Joshua M. ;

Clerc, Philip G. ;

Forbes, Whitney L. ;

Gettle, Morgan C. ;

Wardian, Jana L. ;

Colburn, Jeffrey A. .

ENDOCRINE PRACTICE, 2020, 26 (05) :523-528

[36] Insulin detemir: improving the predictability of glycaemic control [J].

Russell-Jones, D .

INTERNATIONAL JOURNAL OF OBESITY, 2004, 28 (Suppl 2) :S29-S34

[37] Comparison of Insulin Detemir and Insulin Glargine on Glycemic Variability in Patients with Type 1 and Type 2 Diabetes [J].

Tone, A. ;

Iseda, I. ;

Higuchi, C. ;

Tsukamoto, K. ;

Katayama, A. ;

Matsushita, Y. ;

Hida, K. ;

Wada, J. ;

Shikata, K. .

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2010, 118 (05) :320-324

[38] Insulin detemir: improving the predictability of glycaemic control [J].

D Russell-Jones .

International Journal of Obesity, 2004, 28 :S29-S34

[39] Insulin detemir is a fully efficacious, low affinity agonist at the insulin receptor [J].

Sorensen, A. R. ;

Stidsen, C. E. ;

Ribel, U. ;

Nishimura, E. ;

Sturis, J. ;

Jonassen, I. ;

Bouman, S. D. ;

Kurtzhals, P. ;

Brand, C. L. .

DIABETES OBESITY & METABOLISM, 2010, 12 (08) :665-673

[40] Improvement of blood glucose control and reduction of hypoglycemia, body weight, and C-reactive protein in type 1 diabetic patients treated with intensive insulin therapy with insulin analogs [J].

Radenkovic, Saga ;

Golubovic, Milena Velojic ;

Dimic, Dragan ;

Radojkovic, Danijela ;

Ciric, Vojislav ;

Pegic, Milica .

VOJNOSANITETSKI PREGLED, 2024, 81 (08) :480-490

← 1 2 3 4 5 →